“Runner Up: Incidence of Cutaneous Adverse Events With PI3K-Akt-MTOR Pathway Inhibitors: A Systematic Review and Network Meta-Analysis”. 2022. SKIN The Journal of Cutaneous Medicine 6 (3): s39. https://doi.org/10.25251/skin.6.supp.39.